Strong PDGFRA positivity is seen in GISTs but not in other intra-abdominal mesenchymal tumors: Immunohistochemical and mutational analyses

Applied Immunohistochemistry and Molecular Morphology

Volumn 14, Issue 4, 2006, Pages 390-396

  Peterson, Michael R ^a   Piao, Zhe ^a   Weidner, Noel ^a   Yi, Eunhee S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

c kit; CD117; Fibromatosis; GIST; Immunohistochemistry; Leiomyoma; Mutation; PAKT; PDGFRA; Sarcoma; Schwannoma

Indexed keywords

PLATELET DERIVED GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA; PROTEIN KINASE B; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ABDOMINAL TUMOR; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CELL STRUCTURE; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVATION; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MESENCHYME CELL; ONCOGENE C KIT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ABDOMINAL NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FIBROMA; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MALE; MIDDLE AGED; MUTATION; NEURILEMMOMA; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; S100 PROTEINS; SARCOMA; UTERINE NEOPLASMS;

EID: 33751364089     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000203038.33414.a3     Document Type: Article

References (23)

1. D'Amato G, Steinart DM, McAuliffe JC, et al. Update on the biology and therapy of gastrointestinal stromal tumors. Cancer Control. 2005;12:44-56.
2. Nakahara M, Isozaki K, Hirota S. A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology. 1998;115:1090-1095.
3. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459-465.
4. Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer. 2002;38:S39-S51.
5. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299:708-710.
6. Hirota S, Ohashi A, Nishida T, et al. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology. 2003;125:660-667.
7. Pauls K, Merkelbach-Bruse S, Thal D, et al. PDGFRalpha- and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features. Histopathology. 2005;46:166-175.
8. Wardelmann E, Hrychyk A, Merkelbach-Bruse S, et al. Association of platelet-derived growth factor receptor alpha mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors. J Mol Diagn. 2004;6:197-204.
9. Candelaria M, de la Garza J, Duenas-Gonzalez A. A clinical and biological overview of gastrointestinal stromal tumors. Med Oncol. 2005;22:1-10.
10. Cappuzzo F, Magrini E, Ceresoli GL, et al. Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst. 2004;96:1133-1141.
11. Yi ES, Strong CR, Piao Z, et al. Epithelioid gastrointestinal stromal tumor with PDGFRA activating mutation and immunoreactivity. Appl Immunohistochem Mol Morphol. 2005;13:157-161.
12. Massion PP, Taflan PM, Shyr Y, et al. Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression. Am J Respir Crit Care Med. 2004;170:1088-1094.
13. Cao W, Hashibe M, Rao JY, et al. Comparison of methods for DNA extraction from paraffin-embedded tissues and buccal cells. Cancer Detect Prev. 2003;27:397-404.
14. Yamamoto H, Oda Y, Kawaguchi K, et al. c-Kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol. 2004;28:479-488.
15. Lucas DR, al-Abbadi M, Tabaczka P, et al. c-Kit expression in desomoid fibromatosis. Comparative immunohistochemical evaluation of two commercial antibodies. Am J Clin Pathol. 2003;119:339-345.
16. Montgomery E, Torbenson MS, Kaushal M, et al. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol. 2003;26:1296-1301.
17. Yantiss RK, Spiro IJ, Compton CC, et al. Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall: a clinically important differential diagnosis. Am J Surg Pathol. 2000;24:947-957.
18. Rossi G, Valli R, Bertolini F, et al. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract. Histopathology. 2005;46:522-531.
19. Wasag B, Debiec-Rychter M, Pauwels P, et al. Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site. Mod Pathol. 2004;17:889-894.
20. Lasota J, Dansonka-Mieszkowska A, Sobin LH, et al. A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential. Lab Inv. 2004;874-883.
21. Medeiros F, Corless CL, Duensing A, et al. KIT-negative gastrointestinal stromal tumor: proof of concept and therapeutic implications. Am J Surg Pathol. 2004;28:889-894.
22. Kang HJ, Nam SW, Kim H, et al. Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors. Oncogene. 2005;24:1066-1074.
23. Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol. 2004;22:3813-3825.